Search results for "Patients"

showing 10 items of 962 documents

Effect of Intraoperative High Positive End-Expiratory Pressure (PEEP) with Recruitment Maneuvers vs Low PEEP on Postoperative Pulmonary Complications…

2019

Importance: An intraoperative higher level of positive end-expiratory positive pressure (PEEP) with alveolar recruitment maneuvers improves respiratory function in obese patients undergoing surgery, but the effect on clinical outcomes is uncertain. Objective: To determine whether a higher level of PEEP with alveolar recruitment maneuvers decreases postoperative pulmonary complications in obese patients undergoing surgery compared with a lower level of PEEP. Design, Setting, and Participants: Randomized clinical trial of 2013 adults with body mass indices of 35 or greater and substantial risk for postoperative pulmonary complications who were undergoing noncardiac, nonneurological surgery un…

Lung DiseasesMalemedicine.medical_treatmentAtelectasisLung Disease01 natural sciencesBody Mass IndexHypoxemiaPositive-Pressure RespirationPostoperative Complications0302 clinical medicinePEEP postoperative complications obese patientsAnesthesiaRespiratory function030212 general & internal medicineTidal volumeGeneral MedicineMiddle AgedPleural Diseasesrespiratory systemAdult; Anesthesia General; Body Mass Index; Female; Humans; Lung Diseases; Male; Middle Aged; Obesity; Pleural Diseases; Positive-Pressure Respiration; Postoperative Complications; Pulmonary Atelectasis; Respiratory Insufficiency; Surgical Procedures Operative; Tidal Volume; Treatment Outcome; Intraoperative CareOperative3. Good healthTreatment OutcomePneumothoraxSurgical Procedures OperativeAnesthesiaFemalemedicine.symptomRespiratory Insufficiencypsychological phenomena and processesHumancirculatory and respiratory physiologyAdultPulmonary AtelectasisAnesthesia GeneralNO03 medical and health sciencesmental disordersTidal VolumemedicineHumansPleural DiseaseObesity0101 mathematicsGeneralPositive end-expiratory pressureMechanical ventilationSurgical ProceduresIntraoperative CarePulmonary Atelectasibusiness.industry010102 general mathematicsmedicine.diseaserespiratory tract diseasesRespiratory failurePostoperative Complicationbusiness
researchProduct

Thoracic ultrasound: Potential new tool for physiotherapists in respiratory management. A narrative review

2016

International audience; The use of diagnostic ultrasound by physiotherapists is not a new concept; it is frequently performed in musculoskeletal physiotherapy. Physiotherapists currently lack accurate, reliable, sensitive, and valid measurements for the assessment of the indications and effectiveness of chest physiotherapy. Thoracic ultrasound may be a promising tool for the physiotherapist and could be routinely performed at patients' bedsides to provide real-time and accurate information on the status of pleura, lungs, and diaphragm; this would allow for assessment of lung aeration from interstitial syndrome to lung consolidation with much better accuracy than chest x-rays or auscultation…

Lung DiseasesPleural effusionMechanical Ventilationmedicine.medical_treatmentFollow-UpM-Mode SonographyCritical Care and Intensive Care MedicineCritically-Ill Patients0302 clinical medicineOutcome Assessment Health CareMedicineCommunity-Acquired Pneumonia030212 general & internal medicineIntensive-CareLungPhysiotherapyUltrasonographymedicine.diagnostic_testUltrasound3. Good healthDiaphragm (structural system)Lung UltrasoundChestRadiography ThoracicRespiratory therapymedicine.medical_specialtyCritical CarePoint-of-Care SystemsDiaphragmChest physiotherapy03 medical and health sciencesIntensive care[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyUltrasoundHumansIntensive care medicineObstructive Pulmonary-DiseasePhysical Therapy ModalitiesMechanical ventilationbusiness.industryAuscultationSemiologymedicine.diseaseRespiration DisordersDiaphragmatic MovementPleural EffusionOutcome assessment030228 respiratory systemPhysical therapybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Managing patients taking edoxaban in dentistry

2017

Background Anticoagulation therapy is used in several conditions to prevent or treat thromboembolism. A new group of oral anticoagulants with clear advantages over classic dicoumarin oral anticoagulants (warfarin and acenocoumarol) has been developed in recent years. The Food and Drug Administration has approved edoxaban, dabigatran, rivaroxaban and apixaban. Their advantages include: predictable pharmacokinetics, drug interactions and limited food, rapid onset of action and short half-life. However, they lack a specific reversal agent. Material and methods This paper examines the available evidence regarding rivaroxaban and sets out proposals for clinical guidance of dental practitioners t…

MEDLINEDentistryOdontologíaReview030204 cardiovascular system & hematologyCochrane LibraryDabigatran03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEdoxabanmedicineGeneral DentistryAcenocoumarolRivaroxabanbusiness.industryWarfarin030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludstomatognathic diseaseschemistryUNESCO::CIENCIAS MÉDICASApixabanOdontostomatology for the Disabled or Special Patientsbusinessmedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct

Direct oral anticoagulants and its implications in dentistry : a review of literature

2017

Background Four novel direct oral anticoagulants (DOACs) named dabigatran, rivaroxaban, edoxaban and apixaban have been recently introduced to overcome some of the drawbacks of existing anticoagulants. They have less interactions and do not require routine monitoring. However, there is not enough scientific data about the protocol to apply in these patients on DOACs undergoing dental treatment. Thus is necessary to evaluate the potential bleeding risk of these drugs, the possibility of thromboembolic events occurring if they are withdrawn or the need to change to heparin previously. Material and methods A comprehensive search of the PubMed, Scopus and ISI Web of Science databases was conduc…

MEDLINEDentistryReview030204 cardiovascular system & hematologylaw.inventionDabigatran03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRandomized controlled triallawEdoxabanmedicineProspective cohort studyGeneral DentistryRivaroxabanbusiness.industryRetrospective cohort study030206 dentistry:CIENCIAS MÉDICAS [UNESCO]chemistryUNESCO::CIENCIAS MÉDICASOdontostomatology for the Disabled or Special PatientsApixabanbusinessmedicine.drug
researchProduct

Sevoflurane Well-Handled in Children Is Excellent, but in the Wrong Hands Can Be Life-Threatening.

2019

In this retrospective study, 137 children aged 1–6 with ankyloglossia received lingual frenulum cut under sevoflurane inhalation and local anesthesia. The authors evaluated among other objectives, ...

MEDLINESevoflurane03 medical and health sciencesSevoflurane0302 clinical medicineOutpatientsMedicineHumansLocal anesthesiaChildLingual FrenulumAnkyloglossiaRetrospective StudiesInhalationbusiness.industryRetrospective cohort studyhumanitiesstomatognathic diseases030220 oncology & carcinogenesisAnesthesiaAnesthetics Inhalation030211 gastroenterology & hepatologySurgerybusinessAnesthesia Inhalationmedicine.drugJournal of investigative surgery : the official journal of the Academy of Surgical Research
researchProduct

Human bile microbiota: A retrospective study focusing on age and gender

2021

Aims: The emerging biliary colonization of microorganisms in patients with biliary diseases may be devastating. Recent evidence suggests that age and gender may influence changes in the microbial composition of gut microbiota. To study the relationship between these parameters on bile microbiota, we retrospectively reviewed positive bile cultures following an endoscopic retrograde cholangiopancreatography (ERCP) in a QA-certified academic surgical unit of a single institution. Methods: 449 positive bile cultures from 172 Italian patients with diseases of the biliopancreatic system hospitalized from 2006 through 2017 were investigated for aerobic, anaerobic, and fungal organisms. The patient…

Male0301 basic medicineAgingMultivariate analysisGut flora0302 clinical medicineEpidemiologyBile030212 general & internal medicineAged 80 and overCholangiopancreatography Endoscopic RetrogradeEndoscopic retrograde cholangiopancreatographybiologymedicine.diagnostic_testlcsh:Public aspects of medicineGeneral MedicineMiddle AgedInfectious DiseasesItalyFemaleAnaerobic exerciseAdultmedicine.medical_specialty030106 microbiologyGram-Positive Bacterialcsh:Infectious and parasitic diseasesYoung Adult03 medical and health sciencesERCPAge DistributionAntibiotic resistanceInternal medicineGram-Negative BacteriamedicineHumanslcsh:RC109-216MicrobiomeSex DistributionAgedRetrospective StudiesInpatientsbusiness.industryPublic Health Environmental and Occupational HealthGenderRetrospective cohort studylcsh:RA1-1270biology.organism_classificationBactibiliaCross-Sectional StudiesbusinessJournal of Infection and Public Health
researchProduct

Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study

2017

Objectives: To compare the concordance of ceftaroline MIC values by reference broth microdilution (BMD) and Etest (bioMérieux, France) for MSSA and MRSA isolates obtained from PREMIUM (D372SL00001), a European multicentre study. Methods: Ceftaroline MICs were determined by reference BMD and by Etest for 1242 MSSA and MRSA isolates collected between February and May 2012 from adult patients with community-acquired pneumonia or complicated skin and soft tissue infections; tests were performed across six European laboratories. Selected isolates with ceftaroline resistance in broth (MIC >1 mg/L) were retested in three central laboratories to confirm their behaviour. Results: Overall concordance…

Male0301 basic medicineCephalosporinPharmacologiemedicine.disease_causeCommunity-acquired pneumoniaPneumonia StaphylococcalCommunity-Acquired InfectionPharmacology (medical)Pathologie maladies infectieusesAged 80 and overMicrobial Sensitivity TestBroth microdilutionCeftalorine; Staphylococcus aureus; PREMIUM STUDY GROUPCeftalorineMiddle AgedAnti-Bacterial AgentsCommunity-Acquired InfectionsEuropeInfectious DiseasesStaphylococcus aureusStaphylococcus aureuStaphylococcal Skin InfectionsFemaleHumanAdultMicrobiology (medical)medicine.medical_specialtyStaphylococcus aureusAdolescentmedicine.drug_classCephalosporin030106 microbiologyPREMIUM STUDY GROUPMicrobial Sensitivity TestsStaphylococcal Skin InfectionMicrobiologyYoung Adult03 medical and health sciencesInternal medicineAnti-Bacterial AgentmedicineHumansEtestAgedPharmacologyAdult patientsbusiness.industrybiochemical phenomena metabolism and nutritionmedicine.diseasebacterial infections and mycosesMethicillin-resistant Staphylococcus aureusCephalosporinsMethicillin Susceptible Staphylococcus Aureusbusiness
researchProduct

Determinants of patient and health system delay among Italian and foreign-born patients with pulmonary tuberculosis: a multicentre cross-sectional st…

2018

ObjectivesThe aim of this cross-sectional study was to identify key factors associated with patient delay (PD), health system delay (HSD) and total delay (TOTD) in patients with tuberculosis (TB) to inform control programmes.SettingThe study was conducted in four Italian regions in 2014–2016. Data were obtained using a questionnaire including: sociodemographic and lifestyle data, TB comorbidities, patient knowledge and attitudes towards TB, stigma, access to TB care and health-seeking behaviours.ParticipantsPatients’ inclusion criteria were being diagnosed as a new smear positive pulmonary TB case and living in one of the participating Italian regions. Overall, 344 patients from 30 healthca…

Male0301 basic medicineDelayed DiagnosisCross-sectional studySocial StigmaTransportationChest painHealth Services Accessibility0302 clinical medicinetuberculosis patientsWeight lossSurveys and QuestionnairesHealth care1506030212 general & internal medicineMedicine (all)public health policy; quality in health care; social epidemiology; surveillance; tuberculosis patientsGeneral MedicineMiddle AgedItalysurveillanceFemalePublic Healthmedicine.symptomAdultChest Painmedicine.medical_specialtyTuberculosis030106 microbiologyEmigrants and ImmigrantsStigma (botany)Social epidemiologyDizzinessTime-to-Treatmentquality in health care03 medical and health sciencesSex FactorsForeign bornWeight LossmedicineHumans1724Tuberculosis Pulmonarypublic health policybusiness.industryResearchPatient Acceptance of Health Caremedicine.diseasesocial epidemiologytuberculosis patientCross-Sectional StudiesFamily medicinebusiness
researchProduct

Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli

2018

Abstract Objective To develop a risk-scoring tool to predict multidrug-resistant (MDR) etiology in patients with bloodstream infections (BSI) caused by Gram-negative bacilli (GNB). Methods A prospective multicenter study analyzed patients with BSI hospitalized in 31 Internal Medicine wards in Italy from March 2012 to December 2012. Patients with BSI caused by MDR-GNB (non-susceptible to at least one agent in three antimicrobial categories) were compared to those with BSI due to susceptible GNB. A logistic regression to identify predictive factors of MDR-GNB was performed and the odds ratio (OR) were calculated. A score to predict the risk of MDR was developed. Results Of 533 BSI episodes, 2…

Male0301 basic medicineMultivariate analysisGram-negative bacilliHospitalized patientsLogistic regressionLikelihood ratios in diagnostic testingRisk FactorsDrug Resistance Multiple BacterialMedicineAge FactorMultidrug-resistantProspective StudiesMultivariate AnalysiAged 80 and overAge FactorsAnti-Bacterial AgentsHospitalizationItalyBloodstream infections; Gram-negative bacilli; Multidrug-resistantBloodstream infections; Gram-negative bacilli; Multidrug-resistant; Internal MedicineFemaleSettore SECS-S/01 - StatisticaHumanmedicine.medical_specialtyLogistic Model030106 microbiologyBloodstream infection03 medical and health sciencesInternal medicineAnti-Bacterial AgentGram-Negative BacteriaGram-Negative Bacterial InfectionInternal MedicineHumansAgedbusiness.industryRisk FactorGram negative bacilliOdds ratiomedicine.diseaseProspective StudieLogistic ModelsROC CurveBlood CultureBacteremiaMultivariate AnalysisEtiologyBloodstream infectionsGram-Negative Bacterial Infectionsbusiness
researchProduct

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

2017

Background: Rare cancers pose challenges for diagnosis, treatments, and clinical decision making. Information about rare cancers is scant. The RARECARE project defined rare cancers as those with an annual incidence of less than six per 100 000 people in European Union (EU). We updated the estimates of the burden of rare cancers in Europe, their time trends in incidence and survival, and provide information about centralisation of treatments in seven European countries. Methods: We analysed data from 94 cancer registries for more than 2 million rare cancer diagnoses, to estimate European incidence and survival in 2000–07 and the corresponding time trends during 1995–2007. Incidence was calcu…

Male0301 basic medicinePathologypopulation-based registriesCancer Care Facilities; Delivery of Health Care; Europe; Female; Hospitalization; Humans; Incidence; Male; Neoplasms; Rare Diseases; Registries; Survival Rate; Oncology0302 clinical medicineNeoplasmsMedicineRegistriesmedia_commonTumors -- Treatment -- Europeeducation.field_of_studyRelative survivalIncidenceIncidence (epidemiology)RARECARE projectEuropeHospitalizationSurvival RateOncology030220 oncology & carcinogenesis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalemedicine.medical_specialtyHealth surveysPopulationSocio-culturaleCancer Care Facilities03 medical and health sciencesRare DiseasesSDG 3 - Good Health and Well-beingHumansmedia_common.cataloged_instanceCancer -- MortalityRisk factorEuropean unioneducationSurvival rateOncology cancer burden incidence rare cancerpopulation-based registriesrare cancers cancer registry RARECAREbusiness.industryRare cancerCancer -- Patients -- Long-term careCancer registry030104 developmental biologycancer burdenbusinessDelivery of Health CareDemographyRare disease
researchProduct